At a glance
| Chemical family | An antineoplastic (chemotherapy) drug — a second-generation platinum agent and analog of cisplatin |
| CAS number | 41575-94-4 |
| Classification | A NIOSH-listed hazardous drug; genotoxic. Not classified by IARC as a carcinogen — unlike cisplatin (Group 2A). Often mislabelled "Group 2A," which is incorrect for carboplatin |
| Where you encounter it | Only in a home where someone is being treated: excreted in urine and other fluids, depositing on toilet/bathroom surfaces, bedding and laundry |
| Sleep micro-environment relevance | A household caregiver- and laundry-hygiene concern — contaminated bedding and surfaces, not the mattress — for a limited period after each dose |
| Activated carbon capture | Not relevant — a surface/laundry-residue issue managed by gloves, separate laundering and cleaning, not air filtration |
What it is
Carboplatin is a second-generation platinum chemotherapy drug, developed as a gentler analog of cisplatin — it keeps the platinum-DNA mechanism but is easier on the kidneys and nerves, which is why it is widely used for ovarian, lung and other cancers. As with everything in this family, it is first and foremost an important medicine.
Its place here turns on a precise point of classification. Carboplatin is genotoxic and is listed by NIOSH as a hazardous drug requiring careful handling. Regulatory — NIOSH lists carboplatin among hazardous antineoplastic drugs requiring safe-handling precautions But it has not been classified by IARC as a carcinogen — a meaningful difference from its parent cisplatin, which is an IARC Group 2A compound. Inferred — carboplatin is absent from the IARC carcinogen classifications that include cisplatin; the common "Group 2A" label is a misattribution and is corrected here Calling carboplatin a "Group 2A carcinogen," as some summaries do, is simply wrong, and this Atlas does not repeat the error.
How it relates to the bedroom
The household route: excretion onto surfaces and bedding
Carboplatin reaches the sleep environment exactly as its platinum parent does — through the patient's excreta. It is cleared in urine for days after treatment, and hospital monitoring repeatedly finds antineoplastic drugs across patient areas, with the highest levels on the floors of patient lavatories, explicitly tied to the handling of patients' urine. Peer-reviewed — Hedmer et al. 2008 The drugs are not only on surfaces but get into people: most nurses studied carried measurable internal antineoplastic-drug contamination, some of it from skin contact with contaminated surfaces rather than direct handling. Peer-reviewed — Villa et al. 2021
And the bedroom-specific finding: among the tasks that most strongly predicted picking up these drugs, changing the sheets or making the bed of a treated patient stood out. Peer-reviewed — Villa et al. 2023 In a home, that is the family caregiver's job — the exposure this page exists to address.
Keeping it in proportion
The calibration is the same as for the rest of the family. Carboplatin is a genotoxic hazardous drug, so reasonable precautions are warranted — but documented third-party exposures are low-level traces, and the response is sensible hygiene rather than alarm. Inferred — household third-party exposure is low-level; precaution follows the ALARA principle The drug is doing essential work for the patient; the caregiver's task is to keep their own incidental contact low during the short window after each dose.
What the research says
- Not an IARC-classified carcinogen. Genotoxic and NIOSH-hazardous, but not Group 2A — unlike cisplatin. Inferred — corrected from a common misattribution
- Excreted and surface-deposited. Found on patient-lavatory floors, tied to handling of patients' urine. Peer-reviewed — Hedmer et al. 2008
- Reaches people via surfaces. Most studied nurses internally contaminated, partly from skin contact. Peer-reviewed — Villa et al. 2021
- Bedding is a real route. Sheet-changing/bed-making strongly associated with internal contamination. Peer-reviewed — Villa et al. 2023
What helps reduce it
Follow your care team's home-chemo precautions. Generally for about a week after each dose. Inferred — standard home-chemotherapy caregiver guidance
Glove up and launder separately. Disposable gloves for soiled linens and fluids; wash contaminated bedding apart from other laundry with an extra rinse. Peer-reviewed — Villa et al. 2023
Manage the bathroom. Close the lid before flushing and clean surfaces — the documented hot spots. Peer-reviewed — Hedmer et al. 2008
What does NOT help
- Replacing the mattress. The drug is a transient excreted residue, not a bedding ingredient; hygiene and laundering address it. Inferred
- Mislabelling it a Group 2A carcinogen. That overstates the classification; precautions rest on genotoxicity and hazardous-drug status. Inferred
Open research questions
- The real magnitude of any health risk to home caregivers from low-level contact with excreted platinum drugs. Speculation
- Whether carboplatin's gentler toxicity profile relative to cisplatin translates to any difference in third-party exposure risk. Speculation
Citations
- Hedmer M, et al. (2008). Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. Int. Arch. Occup. Environ. Health. Drugs found on most surfaces; highest on patient-lavatory floors, tied to handling patients' urine. Via Consensus. Reference record Peer-reviewed
- Villa A, et al. (2021). Nurses' internal contamination by antineoplastic drugs in hospital centers. Int. Arch. Occup. Environ. Health. 60.8% of nurses internally contaminated; some from skin contact with contaminated surfaces. Via Consensus. Reference record Peer-reviewed
- Villa A, et al. (2023). Factors associated with internal contamination of nurses by antineoplastic drugs. Int. J. Hyg. Environ. Health. Changing sheets / making the bed of a treated patient strongly associated with internal contamination (OR ~10). Via Consensus. Reference record Peer-reviewed
Frequently asked questions
What is carboplatin?
Carboplatin is a platinum-based chemotherapy drug — the gentler, second-generation analog of cisplatin, developed to keep much of cisplatin's anticancer power with less kidney and nerve toxicity. It is widely used for ovarian, lung and other cancers. Like the rest of this family, it is a valuable cancer treatment, and it belongs in a bedroom atlas only because of what happens after a dose: the drug is excreted, and traces reach surfaces and bedding.
Is carboplatin a carcinogen?
Worth stating precisely. Carboplatin is a genotoxic, NIOSH-listed hazardous drug and is handled with the same caution as other chemotherapy agents. But unlike its parent cisplatin — which IARC classifies as probably carcinogenic (Group 2A) — carboplatin has not been classified by IARC as a carcinogen. So it should not be labelled a Group 2A carcinogen; the caution around it is based on its genotoxicity and hazardous-drug status, not a carcinogen classification.
Why does it matter in the bedroom?
Because patients excrete it. As with the other platinum drugs, it is cleared in urine for days after treatment, and hospital studies find antineoplastic drugs on patient-area surfaces — highest on bathroom floors, tied to handling urine — and reaching people through that contamination. Critically, changing the sheets or making the bed of a treated patient is one of the strongest predictors of picking these drugs up. In a home, that task falls to a family caregiver.
What should a caregiver do?
Follow the home-chemotherapy precautions from your care team, generally for about a week after each dose. Wear disposable gloves when handling soiled bedding, clothing or body fluids; launder contaminated linens separately with an extra rinse; close the toilet lid before flushing and clean bathroom surfaces; and wash hands afterward. The aim is to keep a caregiver's incidental exposure as low as reasonably achievable while the patient gets a vital treatment.
Related compounds
Embr is a sleep environment company researching and addressing the chemistry of the bedroom. Research and product development in progress. This page is informational and is not medical advice; follow your care team's guidance.
Last reviewed 2026-06-27. If you find a factual error, contact us.